Transcatheter Aortic Valve Implantation (TAVI) in Patients With Bicuspid Aortic Valve Stenosis – Systematic Review and Meta-Analysis

Phan, Kevin; Wong, Sophia; Phan, Steven; Ha, Hakeem; Qian, Pierre; Yan, Tristan D.

doi:10.1016/j.hlc.2014.12.163

Cited by 52 publications

(40 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Moreover, no difference was found in post-TAVI mean peak gradients, grading of paravalvular leaks (moderate or severe) (25.7% vs. 19.9% respectively, P = 0.29), PMK implantations rate (18.5% vs. 27.9%, P = 0.52), life-threatening bleeding (8.2% vs. 13.9%, P = 0.33) and major bleeding (20% vs. 16.8%, P = 0.88). Furthermore, need for conventional open-heart surgery (1.9% for BAV group and 1.2% for TAV group, P = 0.18) and occurrence of vascular complications (8.6% and 10.1% respectively, P = 0.32) were also comparable between the two groups [39] . Confirming these findings, Sannino et al [40] investigated the efficacy and safety of TAVI in BAV population.…”

Section: Patients With Bicuspid Aortic Valvementioning

confidence: 73%

“…Of note, despite the higher risk for relevant AR among patients with BAV compared with those with TAV, 30-day and 1-year mortality rates were similar in both subsets of patients [38] . A systematic review and meta-analysis conducted by Phan et al [39] analyzed seven studies including a total of 2245 patients (149 with BAV and 2096 with TAV) undergoing TAVI. According to their results, no difference was observed in 30-day mortality between BAV and TAV groups.…”

Section: Patients With Bicuspid Aortic Valvementioning

confidence: 99%

See 1 more Smart Citation

Who is the next for aortic valve implantation? Present and future indications

Verolino¹,

Veneri²,

Carpenito³

et al. 2018

View full text Add to dashboard Cite

Aortic valve stenosis (AS) represents the most prevalent valvular defect worldwide. It is a progressive disease with a long latency interval and a poor prognosis after symptoms present. According to current European Society of Cardiology guidelines, transcatheter aortic valve implantation (TAVI) is recommended in all patients with severe symptomatic AS and a predicted survival longer than one year, who are not suitable for surgical valve replacement. Despite these recommendations, several studies over the past few years suggest extending these indications towards lower risk AS populations. Otherwise, current available operative risk scores such as Society of Thoracic Surgeons score and EuroSCORE, may offer an incomplete risk assessment; in this setting, the Heart Team plays a crucial role in defining the most appropriate therapeutic strategy in patients with AS. In this review, we aim to discuss the current and future indications for TAVI, analyzing available literature according to patients' profile risk (high/mid/low risk) and other specific conditions (valve-in-valve, bicuspid valve and pure aortic regurgitation).

show abstract

Section: Patients With Bicuspid Aortic Valvementioning

confidence: 73%

Section: Patients With Bicuspid Aortic Valvementioning

confidence: 99%

Who is the next for aortic valve implantation? Present and future indications

Verolino¹,

Veneri²,

Carpenito³

et al. 2018

View full text Add to dashboard Cite

show abstract

“…An analysis of 139 low‐ and intermediate‐risk patients (mean STS score 4.9±3.4%) in 12 European centers corroborated these findings with 1‐year mortality of 17.5% 36. Another multicenter observational study comparing TAVR in patients with bicuspid versus tricuspid aortic valves did not demonstrate any difference in 30‐day mortality 40. A comparison of outcomes in high‐risk patients with bicuspid versus tricuspid aortic valves from the German national TAVR registry also demonstrated no difference in 1‐year mortality 39.…”

Section: Do Clinical Trials Of Tavr In Low‐risk Patients Herald the Ementioning

confidence: 75%

Transcatheter Aortic Valve Replacement in Intermediate‐ and Low‐Risk Patients

Rogers

Thourani

Waksman

2018

JAHA

View full text Add to dashboard Cite

“…[8] In registry reviews, patients with BAV who underwent TAVR had much higher risks of paravalvular leakage, malpositioning or migration, perhaps due to their elliptical annular anatomy, irregular (often severe) annular-leaflet calcifications, and possible less holding-wrapping resistance on the implanted valve than in tricuspid aortic valves. [9] Moderate-to-severe paravalvular leakage in BAV patients were more common than non-BAV patients. [9] Mylotte et al [10] found the moderate-to-severe aortic regurgitation incidence as high as 28.4% in BAV patients, while it was only 9% in CoreValve ® pivotal trial, and 12.2% in Partner 1A trial.…”

Section: Discussionmentioning

confidence: 90%

“…[9] Moderate-to-severe paravalvular leakage in BAV patients were more common than non-BAV patients. [9] Mylotte et al [10] found the moderate-to-severe aortic regurgitation incidence as high as 28.4% in BAV patients, while it was only 9% in CoreValve ® pivotal trial, and 12.2% in Partner 1A trial. The annular diameters or working mechanisms of the currently available catheter-based valves may not be always compatible with the calcified and deformed shape of the BAV.…”

Section: Discussionmentioning

confidence: 90%

An emergent surgery for valve migration in transcatheter aortic valve replacement

Depboylu¹

2017

Turk Gogus Kalp Dama

View full text Add to dashboard Cite

ÖZTranskateter aort kapak replasmanı, cerrahi için yüksek riskli olan veya cerrahiye uygun olmayan şiddetli aort darlığı olan hastalarda sıklıkla kullanılan bir tedavi yöntemidir. Bu yöntemin nadir, ancak başlıca komplikasyonlarından biri de genellikle girişim sırasında meydana gelen kapak migrasyonudur. Transkateter aort kapak replasmanı öncesi Kalp Ekibinin değerlendirmesi, kurtarma işlemi olarak yapılacaklar listesini belirler. Muhtemel majör komplikasyonların ve girişimsel planların tartışılması, yaşamı tehdit eden transkateter aort kapak replasmanı komplikasyonları olması durumunda, hastanın hayatını kurtarabilir. Bu yazıda, biküspid aort kapaklı düşük riskli bir hastada transkateter aort kapak replasmanı sırasında gelişen kapak migrasyonunun başarılı cerrahi tedavisi sunuldu.Anah tar söz cük ler: Aort darlığı; protez yetmezliği; cerrahi; transkateter aort kapak replasmanı. ABSTRACTTranscatheter aortic valve replacement is a common treatment method for patients with severe aortic stenosis, who are either at high-risk or non-eligible for surgery. One of the rare, but major complications of this method is valve migration, which usually occurs during the intervention. The assessment of the Heart Team before transcatheter aortic valve replacement is determinant for the "to-do list" for the bail-out procedure. Discussion of the possible major complications and interventional plans may save the patient's life in case of life-threatening transcatheter aortic valve replacement complications. Herein, we report a successful surgical management of valve migration occurred during transcatheter aortic valve replacement in a low-risk patient with bicuspid aortic valve.

show abstract

Transcatheter Aortic Valve Implantation (TAVI) in Patients With Bicuspid Aortic Valve Stenosis – Systematic Review and Meta-Analysis

Cited by 52 publications

References 26 publications

Who is the next for aortic valve implantation? Present and future indications

Who is the next for aortic valve implantation? Present and future indications

Transcatheter Aortic Valve Replacement in Intermediate‐ and Low‐Risk Patients

An emergent surgery for valve migration in transcatheter aortic valve replacement

Contact Info

Product

Resources

About